Facio
-74%
est. 2Y upside i
Salary advance to employees in Brazil.
Rank
#3618
Sector
Fintech
Est. Liquidity
~3Y
Data Quality
Data: LowFacio operates in a high-growth Brazilian fintech market, specifically the promising salary advance and payroll loan segment.
Last updated: March 10, 2026
Facio successfully obtains its financial institution license, allowing it to issue payroll deduction loans directly and expand its product suite beyond salary advances. This regulatory advantage, combined with strong employer partnerships, drives significant market share capture in the growing Brazilian payroll loan segment, pushing its valuation to $300M+ by 2028.
Facio continues to grow steadily within its niche, leveraging employer integrations for salary advance services. It faces ongoing competition from Creditas and other fintechs, and the regulatory licensing process is slower than anticipated. Revenue grows, but valuation reaches approximately $150M, offering moderate upside.
Dominant incumbents like Creditas aggressively expand their salary advance offerings, or new, well-funded competitors emerge with superior technology or lower fees. Facio struggles to secure its financial institution license, limiting its product expansion and ability to compete on interest rates. This leads to stalled growth, a down round, and a valuation drop to $30M or less, significantly eroding common stock value given the preference stack.
Preference Stack Risk
highInvestors hold $20.5M in liquidation preferences, representing 20.5% of the estimated $100M current valuation.
Dilution Risk
moderateAs a Series B company, Facio will likely require at least one to two more funding rounds, leading to further dilution for common shareholders.
Secondary Liquidity
noneThere is no indication of active secondary markets or tender offers for Facio's shares at this stage.
Questions to Ask at the Interview
Strategic questions based on Facio's data — designed to show you've done your homework.
- 1
“Given the high regulatory barrier to becoming a licensed financial institution, what is Facio's contingency plan or alternative strategy if the licensing process faces significant delays or is ultimately unsuccessful?”
- 2
“How does Facio plan to differentiate its salary advance and payroll loan products against direct competitors like Creditas and newer players like Blipay, especially considering some offer zero-interest options?”
- 3
“With $20.5M raised and a Series B round, what is the expected timeline for a liquidity event for employees, and how is the company managing potential dilution from future funding rounds?”
Community
Valuation Sentiment
Our model estimates -74% upside. What do you think?
Anonymous. Do not share material non-public information.
Community Discussion
Comments are reviewed before they appear publicly.
Loading comments...
Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.